Simultaneous radical nephroureterectomy and transurethral distal ureter balloon occlusion and detachment by unknown
WORLD JOURNAL OF 
SURGICAL ONCOLOGY 
Cormio et al. World Journal of Surgical Oncology 2014, 12:345
http://www.wjso.com/content/12/1/345TECHNICAL INNOVATIONS Open AccessSimultaneous radical nephroureterectomy and
transurethral distal ureter balloon occlusion and
detachment
Luigi Cormio1*, Oscar Selvaggio1, Giuseppe Di Fino1, Paolo Massenio1, Francesca Sanguedolce2, Giuliano Ciavotta1,
Vito Mancini1 and Giuseppe Carrieri1Abstract
Background: Distal ureter bladder cuff (DUBC) excision is an essential part of radical nephroureterectomy (RNU)
but there is no agreement on the ideal surgical technique to achieve it. We describe a novel technique for
endoscopic DUBC excision during RNU that complies with the oncological principle of preventing spillage of tumor
cells, by occluding the distal ureter before its excision, while shortening surgical time, and by avoiding repositioning
the patient.
Methods: Between June 2010 and May 2012, 10 patients underwent simultaneous open RNU and transurethral
distal ureter balloon occlusion and detachment using a flexible cystoscope (f-TUDUBOD) in lumbotomy position.
After having ruled out the presence of a concomitant bladder tumor, one surgeon used a flexible cystoscope to
occlude the affected ureter with a 5Fr Fogarty catheter and circumferentially incised the orifice until detaching it
from the bladder with a boogie electrode or a Holmium laser; meanwhile, two other surgeons performed open
RNU through a lumbotomic approach. Data were compared with those of patients who had previously undergone
open RNU after TUDUBOD.
Results: Mean surgical time for simultaneous open RNU and f-TUDUBOD was 113.4 ± 29.2 minutes, significantly
shorter (P <0.01) than that for open RNU after TUDUBOD (154.2 ± 26.4 minutes). There were no complications.
Surgical margins were always negative; at mean follow-up of 31.1 months, there was no recurrence in the perivesical
space and a 20% (2/10) bladder recurrence rate comparing favorably with that (23.1%) observed at 30-month follow-up
in patients who had undergone open RNU after TUDUBOD.
Conclusions: Simultaneous open RNU and f-TUDUBOD proved to be feasible and to represent a safe and effective
means of shortening surgical time, with obvious clinical and economical benefits.
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Radical nephroureterectomy (RNU) with distal ureter
bladder cuff (DUBC) excision is the standard treatment
for high-risk non-invasive and invasive upper tract tran-
sitional cell carcinoma (UT-TCC), but there is no agree-
ment on the ideal technique for DUBC excision [1-3].
The extravesical approach avoids repositioning the pa-
tient but violates the golden rule of excising the DUBC* Correspondence: luigicormio@libero.it
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unless otherwise stated.under direct vision; conversely, the transvesical and the
endoscopic approach allow DUBC excision under direct
vision but require the patient to be repositioned, thus
being time-consuming. Independent of the DUBC exci-
sion technique, the procedure should comply with the
oncological principle of preventive ureteral occlusion
and en bloc specimen removal to avoid spillage and con-
sequent seeding of tumor cells.
To comply with the oncological principle of preventing
spillage of tumor cells, we recently described a technique for
transurethral distal ureter balloon occlusion before detach-
ment called TUDUBOD [4]. Briefly, the patient is placed inLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 2 In female patients, a large pillow is placed between
the two legs at the level of the foot of the contralateral and
the knee of the homolateral leg, to provide an easier access to
the urethra.
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occluded with a balloon catheter to prevent spillage of
tumor cells outside the bladder while excising the
DUBC with a resectoscope; after having completed this
phase, the patient is turned to the lumbotomy position
for open RNU.
To overcome the problem of prolonged surgical time due
to the use of two different patient positions, we subse-
quently attempted to carry out the transurethral procedure
with the patient in the lumbotomy position, simultaneously
to open RNU, using a flexible cystoscope (f-TUDUBOD).
The present study therefore describes the technique for
simultaneous open RNU and f-TUDUBOD and evaluates
its efficacy in shortening surgical time.
Methods
Following Institutional Review Board approval, 10 patients
underwent simultaneous open RNU and f-TUDUBOD
between June 2010 and May 2012. All patients signed a
written informed consent.
After general anesthesia, the patient was placed in the
standard lumbotomy position (Figure 1); in females, a
large pillow was placed between the patient’s legs at the
level of the foot of the contralateral and the knee of the
homolateral leg, to provide an easier access to the urethra
(Figure 2). The surgeon performing open RNU and the
scrub nurse stood posterior to the patient, whereas his
assistant and the surgeon performing the transurethral
procedure stood anterior to the patient; the endoscopic
equipment was placed cranially posterior to the patient.
Using a flexible cystoscope (f-TUDUBOD), a 5Fr Fogarty
occlusion catheter was inserted into the affected ureter; the
distal end of the Fogarty catheter was cut to remove it from
the instrument and a connector used to inflate the balloon
with 1 ml saline for complete ureteral occlusion [4]. The
flexible cystoscope was re-introduced alongside the FogartyFigure 1 The male patient is placed in the standard
lumbotomy position.catheter and the DUBC circumferentially incised up to the
perivesical fat to detach it from the bladder using a
365 μm Holmium laser fiber or a 5Fr boogie electrode
(Figure 3). An 8Fr Nelaton catheter placed alongside the
flexible cystoscope provided continuous bladder drainage
during the procedure. Finally, a 22Fr Foley urethral cath-
eter was left indwelling. Meanwhile, two other surgeons
performed open RNU through a lumbotomic approach as
previously described [4].
Our prospective Institutional Review Board-approved
database for upper tract transitional cell carcinoma (UT-
TCC) was used to compare data of these patients with those
of patients who had previously undergone open RNU after
TUDUBOD. Continuous data were reported as mean ±
standard deviations (SD) and analyzed by the one-way
analysis of variance (ANOVA) or the Mann-Whitney test,
depending on their normal or non-normal distribution, re-
spectively. Differences in rates were assessed using Fisher’s
exact test. Statistical analysis was carried out using com-
mercially available software (MedCalc version 11.1.0.0,
Mariakerke, Belgium). Significance was set at P <0.05.
Results
Patients’ data are summarized in Table 1. All patients pre-
sented with hematuria and were diagnosed with UT-TCCs
by computed tomography (CT) scanning; 9 were scheduled
for RNU, as they had large (>3 cm) UT-TCCs not suitable
for ureteroscopic treatment, whereas 1 with a 1-cm renal
pelvis UT-TCC was scheduled for RNU following uretero-
scopic removal that showed a high-grade pT1 cancer. Two
patients had a history of a low-grade pTa bladder cancer,
which had never recurred following transurethral resection
performed 16 and 47 months before, respectively. Pre-
operatively, all patients had undergone flexible cystoscopy
to rule out concomitant bladder cancer.
Figure 3 Following insertion of a 5Fr Fogarty catheter into the
affected ureter, the DUBC is circumferentially incised up to the
perivesical fat to detach it from the bladder using a 365 μm
Holmium laser fiber (A) or a 5Fr boogie electrode (B).
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TUDUBOD was 113.4 ± 29.2 minutes with a mean surgical
time for f-TUDUBOD of 22.2 ± 6.8 minutes. The laser fiber
was used in five cases and the boogie electrode in the other
five, with no difference in mean surgical time between the
two energy sources. Mean postoperative hospital stay was
6.5 days (range 5 to 10). No patient suffered complications
(Table 1).
Final pathologic tumor staging and grading is described
in Table 1. Surgical margins were always negative for both
kidney specimens and DUBCs. One patient with high-
grade pT3 disease and lymphovascular invasion received
adjuvant chemotherapy. At mean follow-up of 31.1 months,
there was no recurrence in the perivesical space and a 20%
(2/10) bladder recurrence rate, comparing favorably with
that (23.1%) observed at 30-month follow-up in patients
having undergone open RNU after TUDUBOD. However,
bladder recurrences did occur in patients with no history of
previous bladder cancer.
Comparing data with those of patients who had previ-
ously undergone open RNU after TUDUBOD [4], simul-
taneous open RNU and f-TUDUBOD was associated witha significantly shorter surgical time (113.4 ± 29.2 versus
154.2 ± 26.4 minutes; P <0.01). With both techniques, surgi-
cal margins were always negative and there was no recur-
rence in the perivesical space as assessed by yearly follow-up
CT scanning. Finally, the 20% bladder recurrence rate at
31.1 months follow-up for simultaneous open RNU and
f-TUDUBOD compared favorably with that (23.1%) ob-
served at 30-month follow-up in patients having undergone
open RNU after TUDUBOD.
Discussion
RNU is a technique under continuous refinement. Regard-
ing the removal of kidney and proximal ureter, the open
and laparoscopic approaches seem to be equivalent in
terms of efficacy but the potential functional advantages
of the laparoscopic approach should be weighed against
the possibility of the accompanying pneumoperitoneum
increasing the risk of tumor spillage [1].
Much more controversial is the management of the
DUBC [3]. The extravesical approach, though allowing
preventive ureteral occlusion, violates the golden rule of
excising the DUBC under direct vision; as a matter of
fact, the extravesical approach may result in incomplete
excision if too close to the orifice, or damage to the
contralateral ureter if too extended. The open transvesi-
cal approach guarantees DUBC excision under direct vi-
sion after preventive ureteral occlusion but violates
bladder integrity in both cystotomy and DUBC excision
sites in a patient with a urinary tract TCC. Moreover, it
is invasive, difficult in obese patients or those who have
undergone previous pelvic surgery, and is associated
with significant surgical time and postoperative patient
discomfort.
The endoscopic approach provides an attractive, minim-
ally invasive means of performing DUBC excision under
direct vision, providing preventive ureteral occlusion. As a
matter of fact, the risk of tumor cell spillage after the clas-
sical ‘pluck’ technique of transurethral resection of the
intramural ureter without preventive ureteral occlusion is
documented by several cases of extravesical recurrences [5].
Additionally, coagulation of the ureteral orifice before cir-
cumferential incision and detachment of the intramural
ureter was found, in a recent large retrospective multi-
centric study, to be associated with a higher intravesical
recurrence rate as compared to the extra- or transvesical
approaches [3]; thus pointing out the need for complete
ureteral occlusion before endoscopic DUBC excision.
In the last two decades, several techniques for complete
ureteral occlusion before endoscopic DUBC excision have
been described. Transurethral partial circumferential inci-
sion of the intramural ureter, ligation of the orifice with an
endoloop through 2 needlescopic 2 mm ports placed
transvesically, and transurethral completion of DUBC
detachment has been shown to be oncologically safer than
Table 1 Patients’ data
Number of patients 10








f-TUDUBOD 22.2 minutes (20 to 30)
all procedure 113.4 minutes (95 to 140)














Mean follow-up (range) 31.1 months (21 to 44)
Bladder recurrences 2 (20.0%)
DUBC excision site or extravesical
recurrences
0
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[6]. This, and other similar techniques [7,8] of transvesical
laparoscopic DUBC excision, however, are technically diffi-
cult and also violate bladder integrity, making transurethral
techniques more urologist-friendly and oncologically sound
means of ureteral occlusion and DUBC excision.
Transurethral partial circumferential incision of the intra-
mural ureter, ligation of the mushroom-shaped ureteral
stump with a PDS endoloop [9] or a Hem-o-lok clip placed
through the straight working channel of a rigid nephro-
scope [10] before completing DUBC excision, is relatively
fast and easy to perform. However, care must be taken not
to incise the bladder wall through to the perivesical fat
before the ureteral orifice is occluded. To avoid such a
problem, injection of fibrin sealant through a ureteral
catheter [11] or placement of a Fogarty catheter [4] have
been suggested as simple and safe means of occluding thedistal ureter before DUBC excision. However, such tech-
nical refinements, though increasing ease and oncological
safety of RNU, do not overcome the problem of such a
procedure being time-consuming, requiring two different
steps and patient repositioning between these steps.
The use of a flexible cystoscope and a 5Fr electrode
for transurethral DUBC excision (without occlusion) at
the end of laparoscopic RNU has been described as a
mean of avoiding patient repositioning and, secondarily,
providing a ‘gentler’ approach to the ureter in patients
with a large prostatic middle lobe [12].
The present study demonstrates the feasibility of simul-
taneous open RNU and f-TUDUBOD. There was no differ-
ence in using the boogie electrode or the Holmium laser
fiber; the latter had the advantage of working in saline but
the disadvantage of a more difficult coagulation. Whatever
the energy source, f-TUDUBOD was obviously somewhat
more technically demanding than standard TUDUBOD
with a resectoscope. The comparison with open RNU after
TUDUBOD showed that simultaneous open RNU and
f-TUDUBOD provided a significant reduction of surgical
time, by eliminating the mean 40 minutes needed for
TUDUBOD and subsequent patient repositioning [4], and
yielded similar oncologic outcomes.
Potential study limitations include the relatively small
number of patients, the relatively short mean follow-up,
and the technique being unsuitable for tumors located close
to the ureteral orifice; however, this study aimed at deter-
mining the feasibility of simultaneous open RNU and
f-TUDUBOD and its efficacy in shortening surgical time.
Given the promising results obtained in this initial series,
we feel that this technique deserves further investigation.
Conclusions
Simultaneous open RNU and f-TUDUBOD proved to be
feasible and to represent a safe and effective means of short-
ening surgical time, with obvious clinical and economical
benefits. Further studies are needed to determine the feasi-
bility of simultaneous f-TUDUBOD and laparoscopic RNU,
as well as long-term oncologic results of this technique.
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